



Ruthenium-Catalyzed trans-Selective Hydrostannation of Alkynes**




General. Unless stated otherwise, all reactions were carried out under Argon in flame-dried 
glassware. The solvents were purified by distillation over the indicated drying agents and were 
transferred under Argon: THF, Et2O (Mg/anthracene), CH2Cl2, CH3CN (CaH2), hexane, toluene (Na/K), 
EtOH, MeOH (Mg). Flash chromatography: Merck silica gel 60 (40-63 μm).  
MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: ESQ 3000 (Bruker). Accurate mass determinations: 
Bruker APEX III FT-MS (7 T magnet) or MAT 95 (Finnigan).  
NMR spectra were recorded on Bruker DPX 300, AV VIII 300, 400, 500 or 600 spectrometers in the 
solvents indicated; chemical shifts (δ) are given in ppm relative to TMS, coupling constants (J) in Hz. 
The solvent signals were used as references and the chemical shifts converted to the TMS scale 
(CDCl3: δC = 77.16 ppm; residual CHCl3 in CDCl3: δH = 7.26 ppm; CD2Cl2: δC = 54.0 ppm; residual CHDCl2 
in CD2Cl2: δH = 5.32 ppm); proton and carbon assignments were established using NOESY, HSQC, and 
HMBC experiments.  
For clarity, Sn–H couplings of the vinylic protons were omitted in the multiplet analysis, but are given 
in brackets (averaged over 117/119Sn).  
119Sn NMR spectra were recorded on a Bruker AV VIII 300 or Bruker AV VIII 500 spectrometer using 
Me4Sn as external standard. 




3 were prepared according to literature 
procedures and were stored under Argon. [Cp*Ru(cod)Cl] was purchased from Strem and stored 
under Ar. Commercial Bu3SnH is stabilized with 0.05% of 3,5-di-tert-butyl-4-hydroxytoluene, which 
was not removed in any of the reactions described herein. 
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Table S1. trans-Hydrostannation of Unsymmetrical Alkynes (complete list)[a] 
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 unless stated otherwise, all reactions were performed on 0.1-0.2 mmol scale by adding Bu3SnH (1.1 equiv.) over  5 
min to a solution of the substrate and the respective catalyst  in CH2Cl2 (0.2 M) under Ar; 
[b]
 using either 5 mol% of 3 or 
5, or 1.25 mol% of 7; 
[c]











 2.1 mmol scale; 
[g]
 small amounts of the corresponding ketone were also found; 
[h]
 using 1.0 eq. of Bu3SnH; 
[i]
 
the substrate was added over 1.5 h; 
[j]
 the yield refers to the pure Z-configured ß-stannylated isomer obtained by flash 
chromatography; 
[k]




Figure S-1. Olefinic region of the 
1
H NMR spectrum of (Z)-tributyl(dec-5-en-5-yl)stannane prepared by trans-




Sn nuclei; the (E)-configured 
isomer is marked “minor”; the Z:E ratio is ≥ 99:1 
 
(Z)-Tributyl(dec-5-en-5-yl)stannane. Tributyltin hydride (0.99 mL, 3.68 mmol, 1.05 equiv) was added 
dropwise under Argon over 6 min to a stirred solution of 5-decyne (0.63 mL, 3.5 
mmol) and [Cp*Ru(CH3CN)3]PF6 (88.2 mg, 0.175 mmol, 0.05 equiv)
 in CH2Cl2 (17.5 mL, 
0.2 M) at ambient temperature. Once the addition was complete, stirring was 
continued for 15 min before the solvent was evaporated. The residue was purified by filtration through a 
short pad of silica using hexane as the eluent. Evaporation of the product-containing fractions afforded (Z)-
tributyl(dec-5-en-5-yl)stannane as a colorless oil (1.42 g, 94%) (Z/E > 99:1 (NMR)). 1H NMR (400 MHz, 
CDCl3): δ = 5.98 (tt, J = 7.1, 1.2, JSn–H = 137.4 Hz, 1H), 2.25 – 2.05 (m, 2H), 2.03 – 1.91 (m, 2H), 1.59 – 1.39 (m, 
6H), 1.39 – 1.22 (m, 14H), 1.00 – 0.80 (m, 21H); 13C NMR (101 MHz, CDCl3): δ = 143.4, 140.8, 40.6, 34.9, 
33.1, 32.8, 29.4, 27.6, 22.7, 22.4, 14.3, 14.2, 13.8, 10.4;  119Sn NMR (186 MHz, CDCl3): δ = 53.3 ppm; IR 
(film, cm-1): ṽ = 2955, 2922, 2872, 2854, 1463, 1377, 1071. 
(Z)-11-(Tributylstannyl)-1,8-dioxacyclotetradec-11-ene-2,7-dione. Prepared analogously (using 1.1 equiv. 
of Bu3SnH) as a colorless oil (50.1 mg, 97%) (Z/E = 85:15 (NMR)). 
1H NMR (400 MHz, 
CDCl3): δ = 6.01 (tt, J = 6.6, 1.3, JSn–H = 124.5 Hz, 1H), 4.20 – 4.04 (m, 4H), 2.61 – 2.44 (m, 
2H), 2.43 – 2.36 (m, 2H), 2.36 – 2.27 (m, 4H), 1.71 – 1.56 (m, 4H), 1.56 – 1.38 (m, 6H), 
1.39 – 1.24 (m, 6H), 1.07 – 0.78 (m, 6H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, 
CDCl3): δ = 173.4, 173.2, 142.5, 140.0, 63.9, 63.4, 39.8, 35.2, 33.8, 29.3, 27.6, 24.9, 24.5, 13.8, 10.3; 
119Sn 
NMR (112 MHz, CDCl3): δ = 53.1 ppm; IR (film, cm
-1): ṽ = 2954, 2923, 2871, 2853, 1731, 1458, 1378, 1338, 
1266, 1144, 1068, 1047; ESI-MS calcd for C24H44O4SnNa (M+Na




Figure S-2. Olefinic region of the 
1
H NMR spectrum of crude (Z)-11-(tributylstannyl)-1,8-dioxacyclotetradec-11-ene-
2,7-dione formed by hydrostannation in the presence of [Cp*Ru(MeCN)3)]PF6. The fact that the 
3
JSn,H of the major 
isomer is about twice as large as that of the minor isomer shows that the former derives from a trans-addition 





gously as a colorless oil (52.1 mg, 97%) (Z/E = 95:5 (NMR)). 1H NMR (400 MHz, CDCl3): 
δ = 7.84 – 7.73 (m, 1H), 7.60 – 7.51 (m, 1H), 7.55 – 7.44 (m, 2H), 6.16 (t, J = 7.3, JSn–H = 
127.1 Hz, 1H), 4.47 (t, J = 5.8 Hz, 2H), 4.34 (t, J = 5.9 Hz, 2H), 2.74 – 2.52 (m, 2H), 2.43 
(dt, J = 7.1, 5.6 Hz, 2H), 1.52 – 1.32 (m, 6H), 1.26 – 1.16 (m, 6H), 0.99 – 0.81 (m, 6H), 
0.80 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 168.4, 167.5, 141.4, 139.8, 133.8, 131.9, 131.1, 130.5, 
129.5, 128.3, 64.2, 64.1, 38.5, 34.6, 29.2, 27.5, 13.7, 10.4; 119Sn NMR (112 MHz, CDCl3): δ = 52.6 ppm; IR 
(film, cm-1): ṽ = 2954, 2922, 2870, 2851, 1730, 1462, 1376, 1282, 1128, 1072, 1039, 1017; ESI-MS calcd for 
C26H40O4SnNa (M+Na
+) 559.18401; found 559.18418. 
(Z)-2-(Tributylstannyl)but-2-ene-1,4-diyl diacetate. Prepared analogously as a colorless oil (73.8 mg, 80%) 
(Z/E = 99:1 (NMR)); 1H NMR (400 MHz, CDCl3): δ = 6.39 (tt, J = 6.9, 1.6, JSn–H = 106.9 Hz, 
1H), 4.74 – 4.63 (m, 2H), 4.56 – 4.47 (m, 2H), 2.07 (s, 3H), 2.06 (s, 3H), 1.57 – 1.39 (m, 
6H), 1.38 – 1.25 (m, 6H), 1.03 – 0.93 (m, 6H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, 
CDCl3): δ = 170.8, 170.6, 145.6, 135.6, 71.1, 65.7, 29.1, 27.4, 21.10, 21.08, 13.8, 10.6; 
119Sn NMR (112 MHz, 
CDCl3): δ = 48.5 ppm; IR (film, cm
-1): ṽ = 2956, 2925, 2872, 2853, 1740, 1459, 1376, 1217, 1077, 1021; ESI-
MS calcd for C20H38O4SnNa (M+Na
+) 485.16836; found 485.16855. 
(Z)-3-(Tributylstannyl)hex-3-ene-1,6-diyl bis(4-methylbenzene-sulfonate). Prepared analogously as a 
colorless oil (69.6 mg, 98%) (Z/E = 99:1 (NMR)); 1H NMR (400 MHz, CDCl3): δ = 7.77 (dq, J = 
8.5, 2.1 Hz, 4H), 7.39 – 7.31 (m, 4H), 5.85 (tt, J = 7.1, 1.3, JSn–H = 118.0 Hz, 1H), 3.95 (t, J = 
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6.9 Hz, 2H), 3.88 (t, J = 7.4 Hz, 2H), 2.52 – 2.38 (m, 8H), 2.32 (q, J = 7.0 Hz, 2H), 1.45 – 1.31 (m, 6H), 1.32 – 
1.19 (m, 6H), 0.86 (t, J = 7.3 Hz, 9H), 0.84 – 0.79 (m, 6H); 13C NMR (101 MHz, CDCl3): δ = 145.0, 144.9, 142.2, 
137.8, 133.3, 133.2, 130.01, 129.99, 128.1, 128.0, 69.9, 69.6, 39.3, 34.5, 29.2, 27.4, 21.8, 13.8, 10.3; 119Sn 
NMR (112 MHz, CDCl3): δ = 49.5 ppm; IR (film, cm
-1): ṽ = 2955, 2924, 2871, 2853, 1598, 1463, 1360, 1188, 
1174, 1097; ESI-MS calcd for C32H50O6S2SnNa (M+Na
+) 737.19623; found 737.19663. 
 (Z)-Tributyl(1,12-dibromododec-6-en-6-yl)stannane. Prepared analogously as a colorless oil (49.1 mg, 
80%). (Z/E = 97:3 (NMR)); 1H NMR (400 MHz, CDCl3): δ = 5.97 (tt, J = 7.2, 1.2, JSn–H = 134.3 Hz, 
1H), 3.40 (td, J = 6.8, 3.3 Hz, 4H), 2.26 – 2.06 (m, 2H), 2.04 – 1.93 (m, 2H), 1.93 – 1.78 (m, 
4H), 1.57 – 1.37 (m, 12H), 1.37 – 1.25 (m, 8H), 0.99 – 0.80 (m, 15H); 13C NMR (101 MHz, 
CDCl3): δ = 143.6, 140.6, 40.6, 34.9, 34.1, 33.9, 33.0, 32.9, 29.9, 29.6, 29.4, 28.2, 27.9, 27.6, 13.7, 10.5; 
119Sn 
NMR (112 MHz, CDCl3): δ = 53.2 ppm; IR (film, cm
-1): ṽ = 2955, 2924, 2870, 2853, 1459, 1264, 1071. 
(Z)-Tributyl(1,12-diazidododec-6-en-6-yl)stannane. Prepared analogously as a yellow oil (30.2 mg, 56%) 
(Z/E = 98:2 (NMR)); 1H NMR (400 MHz, CDCl3) δ = 5.97 (tt, J = 7.1, 1.3, JSn–H = 134.3 Hz, 1H), 
3.31 – 3.22 (m, 4H), 2.27 – 2.05 (m, 2H), 2.05 – 1.91 (m, 2H), 1.67 – 1.54 (m, 4H), 1.53 – 1.42 
(m, 6H), 1.42 – 1.36 (m, 4H), 1.36 – 1.25 (m, 10H), 0.99 – 0.80 (m, 15H); 13C NMR (101 MHz, 
CDCl3) δ = 143.6, 140.6, 51.64, 51.57, 40.6, 34.9, 30.2, 30.0, 29.4, 29.0, 28.9, 27.6, 26.7, 26.4, 13.8, 10.4; 
119Sn NMR (112 MHz, CDCl3): δ = 53.1 ppm; IR (film, cm
-1): ṽ = 2954, 2925, 2870, 2854, 2090, 1457, 1347, 
1256, 1072. 
(Z)-N1,N8-Dimethoxy-N1,N8-dimethyl-4-(tributylstannyl)oct-4-enediamide. Prepared analogously as a 
yellow oil (48.2 mg, 88%) (Z/E = 99:1 (NMR)); 1H NMR (500 MHz, CDCl3): δ = 
6.07 (t, J = 7.1, JSn–H = 128.4 Hz, 1H), 3.67 (s, 6H), 3.17 (s, 3H), 3.16 (s, 3H), 2.54 – 
2.36 (m, 6H), 2.30 (dt, J = 9.4, 7.2 Hz, 2H), 1.57 – 1.39 (m, 6H), 1.37 – 1.25 (m, 
6H), 1.01 – 0.86 (m, 6H), 0.87 (t, J = 7.3 Hz, 9H); 13C NMR (126 MHz, CDCl3): δ = 174.2, 173.9, 143.5, 139.7, 
61.3, 61.3, 33.1, 32.5, 32.3, 29.9, 29.4, 27.5, 13.8, 10.3; 119Sn NMR (186 MHz, CDCl3): δ = 51.0 ppm; IR 
(film, cm-1): ṽ = 2955, 2924, 2871, 2853, 1665, 1462, 1413, 1380, 1176, 1115, 1073, 992; ESI-MS calcd for 
C24H48N2O4SnNa (M+Na
+) 571.25276; found 571.25288. 
(Z)-7-(Tributylstannyl)tetradec-7-ene-1,14-diol. Prepared analogously as a yellow oil (39.4 mg, 76%) (Z/E = 
99:1 (NMR)); 1H NMR (400 MHz, CDCl3): δ = 5.96 (tt, J = 7.0, 1.2, JSn–H = 136.3 Hz, 1H), 
3.63 (tdd, J = 6.6, 4.6, 1.8 Hz, 4H), 2.24 – 2.05 (m, 2H), 2.03 – 1.90 (m, 2H), 1.63 – 1.53 
(m, 4H), 1.53 – 1.40 (m, 6H), 1.40 – 1.23 (m, 20H), 0.97 – 0.79 (m, 6H), 0.89 (t, J = 7.2 
Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 143.5, 140.8, 63.22, 63.16, 40.7, 35.1, 33.0, 32.9, 30.7, 30.5, 29.43, 
29.39, 29.1, 27.6, 25.9, 25.8, 13.8, 10.4; 119Sn NMR (112 MHz, CDCl3): δ = 53.5 ppm; IR (film, cm
-1): ṽ = 




analogously as a yellow oil (66.3 mg, 89%) (Z/E = 99:1 (NMR)); 1H NMR (400 MHz, 
CDCl3): δ = 5.97 (tt, J = 7.1, 1.2, JSn–H = 137.0 Hz, 1H), 3.60 (td, J = 6.6, 1.3 Hz, 4H), 
2.26 – 2.03 (m, 2H), 1.96 (q, J = 6.9 Hz, 2H), 1.61 – 1.40 (m, 10H), 1.40 – 1.21 (m, 
18H), 1.03 – 0.77 (m, 33H), 0.05 (s, 12H); 13C NMR (101 MHz, CDCl3): δ = 143.5, 140.7, 63.5, 63.4, 40.9, 35.2, 
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33.11, 33.06, 30.9, 30.6, 29.5, 29.4, 29.2, 27.6, 26.2, 26.0, 25.9, 18.5, 13.9, 10.4, 5.1; 119Sn NMR (112 MHz, 
CDCl3): δ = 53.4 ppm; IR (film, cm
-1): ṽ = 2954, 2926, 2855, 1462, 1387, 1361, 1253, 1099, 1005; ESI-MS 
calcd for C38H82O2Si2SnNa (M+Na
+) 769.47669; found 769.47757. 
(Z)-9-(Tributylstannyl)octadec-9-ene-2,17-dione. Prepared analogously as a colorless oil (53.3 mg, 94%) 
(Z/E = 99:1 (NMR)); 1H NMR (400 MHz, CDCl3) δ = 5.94 (tt, J = 7.1, 1.3, JSn–H = 136.3 Hz, 1H), 
2.40 (td, J = 7.5, 1.8 Hz, 4H), 2.18 – 2.03 (m, 2H), 2.12 (s, 6H), 1.99 – 1.91 (m, 2H), 1.61 – 
1.51 (m, 4H), 1.50 – 1.41 (m, 6H), 1.37 – 1.21 (m, 18H), 0.95 – 0.79 (m, 15H); 13C NMR (101 
MHz, CDCl3) δ = 209.4, 209.3, 143.5, 140.7, 44.0, 43.9, 40.8, 35.1, 30.7, 30.3, 29.97, 29.95, 29.41, 29.39, 
29.36, 29.25, 29.1, 27.6, 24.1, 24.0, 13.8, 10.4; 119Sn NMR (112 MHz, CDCl3): δ = 53.9 ppm; IR (film, cm
-1): ṽ 
= 2953, 2923, 2870, 2852, 1717, 1458, 1417, 1357, 1161, 1071; ESI-MS calcd for C30H59O2Sn (M+H
+) 
571.35364; found 571.35409. 
(Z)-2,2'-(9-(Zributylstannyl)octadec-9-ene-1,18-diyl)bis(isoindoline-1,3-dione). Prepared analogously as a 
colorless oil (81.2 mg, 98%) (Z/E = 99:1 (NMR)); 1H NMR (400 MHz, CDCl3): δ = 
7.88 – 7.78 (m, 4H), 7.75 – 7.65 (m, 4H), 5.95 (tt, J = 7.1, 1.2, JSn–H = 137.1 Hz, 1H), 
3.67 (dd, J = 8.0, 6.7 Hz, 4H), 2.20 – 2.00 (m, 2H), 1.98 – 1.88 (m, 2H), 1.72 – 1.60 
(m, 4H), 1.54 – 1.38 (m, 6H), 1.37 – 1.18 (m, 26H), 0.96 – 0.78 (m, 6H), 0.87 (t, J = 
7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 168.6, 143.5, 140.7, 133.9, 132.4, 123.3, 40.8, 38.3, 38.2, 35.2, 
30.8, 30.5, 29.7, 29.59, 29.58, 29.42, 29.36, 29.3, 28.8, 27.6, 27.07, 27.05, 13.8, 10.4; 119Sn NMR (112 MHz, 
CDCl3): δ = 53.5 ppm; IR (film, cm
-1): ṽ = 2922, 2852, 1773, 1709, 1465, 1436, 1394, 1367, 1188, 1060; ESI-
MS calcd for C46H68N2O4SnNa (M+Na
+) 855.40926; found 855.40912. 
Diethyl 2-(tributylstannyl)fumarate.6 Prepared analogously as a colorless oil (63.8 mg, 69%) (Z/E = 94:6 
(NMR)); 1H NMR (400 MHz, CDCl3): δ = 6.82 (s, JSn–H = 81.8 Hz, 1H), 4.22 (q, J = 7.1 Hz, 2H), 
4.20 (q, J = 7.2 Hz, 2H), 1.58 – 1.37 (m, 6H), 1.37 – 1.24 (m, 12H), 1.14 – 0.94 (m, 6H), 0.88 
(t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 172.5, 167.4, 161.7, 134.8, 61.19, 61.15, 
29.1, 27.4, 14.43, 14.36, 13.8, 12.1; 119Sn NMR (112 MHz, CDCl3): δ = 37.0 ppm; IR (film, cm
-1): ṽ = 2956, 
2921, 2872, 2853, 1709, 1463, 1367, 1313, 1193, 1036; ESI-MS calcd for C20H38O4Sn+Na (MNa
+) 485.16836; 
found 485.16858. 
(Z)-(1,2-Bis(4-(trifluoromethyl)phenyl)vinyl)tributylstannane. Prepared analogously as a colorless oil (120 
mg, 98%) (Z/E = 98:2 (NMR)); 1H NMR (400 MHz, CD2Cl2): δ = 7.65 (d, J = 8.0 Hz, 
2H), 7.60 (d, J = 8.0 Hz, 2H), 7.48 (d, J = 8.4 Hz, 2H), 7.43 (s, 1H), 7.29 (d, J = 8.0 Hz, 
2H), 1.40 – 1.22 (m, 6H), 1.21 – 1.10 (m, 6H), 0.78 (t, J = 7.3 Hz, 9H), 0.82 – 0.63 
(m, 6H); 13C NMR (101 MHz, CD2Cl2): δ = 152.9, 152.4, 145.0, 143.5, 128.8, 127.6, 125.83, 125.79, 125.76, 
125.72, 125.69, 125.65, 29.4, 27.8, 13.8, 12.3; 119Sn NMR (112 MHz, CDCl3): δ = 43.5 ppm; IR (film, cm
-1): ṽ 
= 2957, 2925, 2873, 2854, 1612, 1319, 1163, 1123, 1105, 1065, 1016. 
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3
JSn,H = 81.8 Hz is significantly smaller than for most other products described herein; yet, 
it is in good agreement with the literature, which reports a 
3
JSn,H = 83.5 Hz for the Z-isomer and 50.0 Hz for the E-
isomer, cf. ref. 4. 
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(Z)-3-(Tributylstannyl)pent-3-en-2-ol. Tributyltin hydride (1.1 mmol, 0.30 mL, 1.1 equiv) was added 
dropwise over 5 min to a stirred solution of [Cp*RuCl2]n (15.4 mg, 0.025 mmol, 0.025 equiv)
 and 
3-pentyn-2-ol (93 μL, 1.0 mmol) in CH2Cl2 (5.0 mL, 0.2 M) under argon. The resulting mixture was 
stirred for 15 min before all volatile materials were evaporated. The residue was loaded on top 
of a flash column packed with SiO2 and the product eluted with hexane/EtOAc (50/130/1) to give the title 
compound as a pale yellow oil (329 mg, 88%, α/β isomer = 98/2). The Z/E ratio was found to be >99/1 for 
the α-isomer. 1H NMR (400 MHz, CDCl3): δ = 6.27 (qd, J = 6.7, 1.2, JSn–H = 125.5 Hz, 1H), 4.35 (qd, J = 6.3, 3.1 
Hz, 1H), 1.76 – 1.69 (m, 3H), 1.60 – 1.40 (m, 6H), 1.39 – 1.28 (m, 7H), 1.21 (d, J = 6.3 Hz, 3H), 1.07 – 0.92 (m, 
6H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 150.5, 133.6, 75.8, 29.4, 27.5, 24.4, 19.3, 13.8, 
11.0; 119Sn NMR (186 MHz, CDCl3): δ = 54.6 ppm; IR (film, cm
-1): ṽ = 3345, 2955, 2922, 2871, 2853, 1621, 
1456, 1375, 1289, 1248, 1069; ESI-MS calcd for C17H35OSn (M–H
–) 375.17147; found 375.17160. 
 
Figure S-3. Olefinic region of the 
1
H NMR spectrum of the crude product formed by hydrostannation of 3-pentyn-2-ol 
in the presence of [Cp*Ru(MeCN)3]PF6 (3) (top, black) or [Cp*RuCl]4 (7) (bottom, red), respectively; although the 
reaction catalyzed by 3 is regio-unselective, both isomers obviously originate from a trans-addition process as evident 
from the characteristic 
3
JSn,H coupling constants (expressed in the satellites) which are of the same magnitude. 
 
(Z)-2-(Tributylstannyl)pent-2-en-1-ol. Prepared analogously using [(Cp*RuCl)4] (1.25 mol%) as the catalyst; 
colorless oil (670 mg, 83%) (α/β = 95/5) (Z/E = 99:1 for the major isomer (NMR)); 1H NMR 
(400 MHz, CDCl3): δ = 6.21 (tt, J = 7.1, 1.4, JSn–H = 122.9 Hz, 1H), 4.25 – 4.08 (m, 2H), 2.10 – 
1.98 (m, 2H), 1.59 – 1.39 (m, 6H), 1.38 – 1.25 (m, 6H), 1.20 (t, J = 5.9 Hz, 1H), 1.06 – 0.92 (m, 
9H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 143.6, 142.6, 70.6, 29.4, 27.9, 27.5, 14.6, 13.8, 
10.4; 119Sn NMR (112 MHz, CDCl3): δ = 52.3 ppm; IR (film, cm
-1): ṽ = 3316, 2956, 2923, 2871, 2851, 1622, 
1459, 1418, 1376, 1291, 1148, 1080, 1000; ESI-MS calcd for C17H35OSn (M–H




(Z)-3-(Tributylstannyl)hex-3-en-2-ol. Prepared analogously using [(Cp*RuCl)4] (1.25 mol%) as the catalyst; 
colorless oil (65.5 mg, 84%) (α/β = 98/2) (Z/E = 99:1 for the major isomer (NMR)); 1H NMR (400 
MHz, CDCl3): δ = 6.15 (td, J = 7.2, 1.1, JSn–H = 125.7 Hz, 1H), 4.34 (qdd, J = 6.4, 3.4, 1.0 Hz, 1H), 
2.09 – 1.94 (m, 2H), 1.59 – 1.39 (m, 6H), 1.38 – 1.26 (m, 7H), 1.22 (d, J = 6.3 Hz, 3H), 1.09 – 
0.92 (m, 9H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 148.4, 141.2, 75.7, 29.4, 27.6, 27.5, 
24.4, 14.6, 13.8, 11.2; 119Sn NMR (112 MHz, CDCl3): δ = 53.8 ppm; IR (film, cm
-1): ṽ = 3354, 2957, 2923, 
2871, 2853, 1619, 1458, 1376, 1287, 1247, 1149, 1115, 1070, 1005; ESI-MS calcd for C18H37OSn (M–H
–) 
389.18712; found 389.18728. 
(Z)-3-(Tributylstannyl)hex-3-en-2-yl acetate. Prepared analogously using [(Cp*RuCl)4] (1.25 mol%) as the 
catalyst; colorless oil (73.8 mg, 86%) (α/β = 75:25) (Z/E = 94:6 for the major isomer (NMR)); 1H 
NMR (400 MHz, CDCl3): δ = 6.18 (td, J = 7.2, 1.0, JSn–H = 122.3 Hz, 1H), 5.49 – 5.28 (m, 1H), 2.08 
– 1.94 (m, 2H), 2.00 (s, 3H), 1.59 – 1.38 (m, 6H), 1.38 – 1.27 (m, 6H), 1.25 (d, J = 6.4 Hz, 3H), 
1.05 – 0.85 (m, 18H); 13C NMR (101 MHz, CDCl3): δ = 170.2, 151.1, 143.5, 78.6, 29.3, 27.54, 27.50, 22.1, 
21.7, 14.4, 13.8, 11.1; 119Sn NMR (112 MHz, CDCl3): δ = 52.4 ppm; IR (film, cm
-1): ṽ = 2957, 2926, 2871, 
2854, 1737, 1457, 1368, 1235, 1126, 1070, 1041, 1012; ESI-MS calcd for C20H40O2SnNa (M+Na
+) 455.19418; 
found 455.19459. 
(2Z,7Z)-3-(Tributylstannyl)trideca-2,7-dien-4-ol. Prepared analogously using [(Cp*RuCl)4] (1.25 mol%) as 
the catalyst; colorless oil (69.5 mg, 72%) (α/β = 98:2) (Z/E = 99:1 for the major isomer 
(NMR)); 1H NMR (400 MHz, CDCl3): δ = 6.25 (qd, J = 6.6, 1.1, JSn–H = 125.5 Hz, 1H), 5.44 – 
5.30 (m, 2H), 4.13 (td, J = 6.7, 3.1 Hz, 1H), 2.16 – 1.95 (m, 4H), 1.74 (d, J = 6.5 Hz, 3H), 
1.60 – 1.42 (m, 8H), 1.41 (d, J = 3.2 Hz, 1H), 1.39 – 1.23 (m, 12H), 1.08 – 0.93 (m, 6H), 0.92 – 0.84 (m, 12H); 
13C NMR (101 MHz, CDCl3): δ = 149.3, 134.9, 130.7, 129.2, 80.0, 37.8, 31.7, 29.6, 29.4, 27.6, 27.4, 24.0, 22.8, 
19.4, 14.2, 13.8, 11.1; 119Sn NMR (112 MHz, CDCl3): δ = 55.6 ppm; IR (film, cm
-1): ṽ = 3466, 3004, 2955, 
2922, 2871, 2854, 1620, 1457, 1376, 1290, 1070, 1003; ESI-MS calcd for C25H49OSn (M–H
–)  485.28102; 
found 485.28128. 
(Z)-3-(Tributylstannyl)octa-2,7-dien-4-ol. Prepared analogously using [(Cp*RuCl)4] (1.25 mol%) as the 
catalyst; colorless oil (31.9 mg, 77%) (α/β = 97:3) (Z/E = 99:1 for the major isomer (NMR)); 
1H NMR (400 MHz, CDCl3): δ = 6.25 (qd, J = 6.7, 1.1, JSn–H = 125.0 Hz, 1H), 5.83 (ddt, J = 16.9, 
10.2, 6.6 Hz, 1H), 5.02 (dq, J = 17.1, 1.7 Hz, 1H), 4.96 (ddt, J = 10.2, 2.3, 1.3 Hz, 1H), 4.24 – 
4.02 (m, 1H), 2.19 – 1.96 (m, 2H), 1.74 (d, J = 6.6 Hz, 3H), 1.66 – 1.42 (m, 8H), 1.41 (d, J = 3.1 Hz, 1H), 1.39 – 
1.22 (m, 6H), 1.09 – 0.69 (m, 6H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 149.3, 138.7, 135.0, 
114.8, 79.9, 36.9, 30.4, 29.4, 27.6, 19.4, 13.8, 11.1; IR (film, cm-1): ṽ = 3429, 2956, 2922, 2871, 2853, 1641, 
1620, 1456, 1376, 1260, 1071, 1046, 1016; ESI-MS calcd for C20H40OSnNa (M+Na
+) 439.19926; found 
439.19957. 
(Z)-1-(1-(Tributylstannyl)prop-1-en-1-yl)cyclohexan-1-ol. Prepared analogously using [(Cp*RuCl)4] (1.25 
mol%) as the catalyst; colorless oil (82.9 mg, 97%) (α/β = 99:1) (Z/E = 99:1 for the major isomer 
(NMR)); 1H NMR (400 MHz, CDCl3): δ = 6.24 (q, J = 6.7, JSn–H = 137.8 Hz, 1H), 1.74 (d, J = 6.6 Hz, 
3H), 1.69 – 1.53 (m, 6H), 1.53 – 1.38 (m, 9H), 1.38 – 1.27 (m, 6H), 1.26 (s, 1H), 1.22 – 1.07 (m, 
1H), 1.06 – 0.86 (m, 6H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 155.3, 130.3, 75.7, 38.2, 
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29.4, 27.6, 25.7, 22.4, 19.3, 13.9, 12.4; 119Sn NMR (112 MHz, CDCl3): δ = 55.7 ppm; IR (film, cm
-1): ṽ = 3449, 
2953, 2923, 2870, 2852, 1448, 1375, 1340, 1293, 1253, 1149, 1071; ESI-MS calcd for C21H42OSnNa (M+Na
+) 
453.21492; found 453.21520. 
(Z)-3-(Tributylstannyl)pent-3-en-1-ol. Prepared analogously using [(Cp*RuCl)4] (1.25 mol%) as the catalyst; 
colorless oil (61.0 mg, 81%) (α/β = 81:19) (Z/E = 95:5 for the major isomer (NMR)); Data of 
the major isomer: 1H NMR (400 MHz, CDCl3): δ = 6.20 (qt, J = 6.6, 1.3, JSn–H = 129.6 Hz, 1H), 
3.53 (q, J = 6.1 Hz, 2H), 2.53 – 2.34 (m, 2H), 1.74 (dt, J = 6.6, 0.9 Hz, 3H), 1.60 – 1.37 (m, 7H), 
1.37 – 1.25 (m, 6H), 1.03 – 0.84 (m, 6H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 140.7, 138.6, 
61.8, 43.6, 29.3, 27.5, 20.2, 13.8, 10.3; 119Sn NMR (112 MHz, CDCl3): δ = 52.6 ppm; IR (film, cm
-1): ṽ = 3319, 
2955, 2922, 2871, 2852, 1620, 1462, 1418, 1376, 1291, 1181, 1040; ESI-MS calcd for C17H35OSn (M–H
–) 
375.17147; found 375.17149. 
(Z)-4-(Tributylstannyl)hex-4-en-1-ol. Prepared analogously using [(Cp*RuCl)4] (1.25 mol%) as the catalyst; 
colorless oil (66.7 mg, 86%) (α/β = 83:17) (Z/E = 99:1 for the major isomer (NMR)); Data of 
the major isomer: 1H NMR (400 MHz, CDCl3): δ = 6.12 (qt, J = 6.6, 1.3, JSn–H = 132.7 Hz, 1H), 
3.68 – 3.58 (m, 2H), 2.24 (ddt, J = 8.7, 6.3, 1.2 Hz, 2H), 1.70 (dt, J = 6.6, 1.0 Hz, 3H), 1.66 – 
1.38 (m, 8H), 1.38 – 1.23 (m, 7H), 1.02 – 0.83 (m, 6H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 
144.3, 135.0, 62.8, 37.1, 33.6, 29.4, 27.6, 20.0, 13.8, 10.3; 119Sn NMR (112 MHz, CDCl3): δ = 53.0 ppm; IR 
(film, cm-1): ṽ = 3318, 2955, 2923, 2871, 2852, 1456, 1376, 1291, 1180, 1071, 1052, 1002; ESI-MS calcd for 
C18H37OSn (M–H
–) 389.18712; found 389.18720. 
(Z)-4-Methyl-N-(3-(tributylstannyl)hex-3-en-2-yl)benzenesulfonamide. Prepared analogously using 
[(Cp*RuCl)4] (1.25 mol%) as the catalyst; colorless oil (48.7 mg, 90%) (α/β = 99:1) (Z/E = 99:1 
(NMR)); 1H NMR (400 MHz, CDCl3): δ = 7.74 – 7.66 (m, 2H), 7.30 – 7.22 (m, 2H), 5.93 (td, J = 
7.2, 1.0, JSn–H = 120.7 Hz, 1H), 4.30 (d, J = 6.3 Hz, 1H), 4.04 – 3.81 (m, 1H), 2.41 (s, 3H), 1.94 – 
1.79 (m, 2H), 1.53 – 1.32 (m, 6H), 1.37 – 1.22 (m, 6H), 1.14 (d, J = 6.7 Hz, 3H), 0.95 – 0.72 (m, 18H); 13C NMR 
(101 MHz, CDCl3): δ = 144.4, 143.2, 142.6, 138.2, 129.6, 127.5, 58.5, 29.3, 27.7, 27.5, 23.9, 21.6, 14.3, 13.8, 
11.0; 119Sn NMR (112 MHz, CDCl3): δ = 52.9 ppm; IR (film, cm
-1): ṽ = 3268, 2956, 2924, 2871, 2853, 1456, 
1417, 1374, 1325, 1160, 1094, 1071; ESI-MS calcd for C25H45NO2SSnNa (M+Na
+) 566.20845; found 
566.20883. 
(Z)-Tributyl(1-(4-(trifluoromethyl)phenyl)prop-1-en-1-yl)stannane. Prepared analogously using 
[Cp*Ru(CH3CN)3]PF6 as the catalyst; colorless oil (88.4 mg, 93%) (α/β = 65:35) (Z/E = 99:1, 
α-isomer (NMR)); Data of major α-isomer: 1H NMR (500 MHz, CD2Cl2): δ = 7.53 – 7.48 (m, 
2H), 7.12 (d, J = 7.9 Hz, 2H), 6.32 (q, J = 6.7 Hz, 1H), 1.91 (d, J = 6.7 Hz, 3H), 1.51 – 1.40 (m, 
6H), 1.32 – 1.24 (m, 6H), 1.05 – 0.89 (m, 6H), 0.86 (t, J = 7.3 Hz, 9H); 13C NMR (126 MHz, CD2Cl2, resolved 
signals): δ = 152.7, 146.2, 140.3, 127.7, 127.3, 125.4, 125.4, 125.4, 125.3, 29.6, 27.9, 20.8, 14.0, 11.4; 119Sn 
NMR (186 MHz, CD2Cl2): δ = 48.1 ppm; IR (film, cm
-1): ṽ = 2957, 2925, 2872, 2853, 1614, 1463, 1377, 1322, 
1162, 1123, 1105, 1067, 1016. 
 (Z)-Tributyl(4-methylpent-2-en-3-yl)stannane. Prepared analogously using [Cp*Ru(CH3CN)3]PF6 as the 
catalyst; colorless oil (67.1 mg, 90%) (α/β = 79:21) (Z/E = 99:1, α-isomer; Z/E = 57:43, β-isomer 
(NMR)); α-isomer: 1H NMR (400 MHz, CDCl3): δ = 6.10 (qd, J = 6.6, 1.2, JSn–H = 139.8 Hz, 1H), 2.51 
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– 2.29 (m, 1H), 1.74 – 1.66 (m, 3H), 1.60 – 1.38 (m, 6H), 1.39 – 1.24 (m, 6H), 0.97 (d, J = 6.8 Hz, 6H), 0.90 (t, J 
= 7.3 Hz, 9H), 1.00 – 0.86 (m, 6H); 13C NMR (101 MHz, CDCl3): δ = 152.3, 130.5, 38.0, 29.4, 27.6, 23.4, 19.8, 
13.8, 10.9; 119Sn NMR (112 MHz, CDCl3): δ = 53.6 ppm; IR (film, cm
-1): ṽ = 2955, 2923, 2871, 2855, 1462, 
1376, 1359, 1339, 1288, 1181, 1071, 1002. 
(Z)-2-(Tributylstannyl)hex-2-enoic acid. Prepared analogously using [(Cp*RuCl)4] (1.25 mol%) as the 
catalyst and limiting the amount of Bu3SnH to exactly 1 equivalent relative to the 
substrate; colorless oil (389 mg, 87%) (α/β = 90:10) (Z/E = 96:4 (NMR)); 1H NMR (500 MHz, 
CDCl3): δ =7.50 (t, J = 7.3, JSn–H = 103 Hz, 1H), 2.17 (q, J = 7.4 Hz, 2H), 1.56 – 1.41 (m, 8H), 
1.37 – 1.27 (m, 6H), 1.09 – 0.85 (m, 18H); 13C NMR (126 MHz, CDCl3): δ = 177.5, 160.2, 135.8, 36.3, 29.2, 
27.4, 22.5, 14.0, 13.8, 11.5; 119Sn NMR (186 MHz, CDCl3): δ = 45.7 ppm; IR (film, cm
-1): ṽ = 3042, 2956, 
2922, 2871, 2853, 2621, 1662, 1600, 1462, 1404, 1377, 1272, 1073; ESI-MS calcd for C18H35O2Sn (M–H
–) 
403.16638; found 403.16671. 
(Z)-4-(Tributylstannyl)hex-4-enoic acid. Prepared analogously using [(Cp*RuCl)4] (1.25 mol%) as the 
catalyst and limiting the amount of Bu3SnH to exactly 1 equivalent relative to the 
substrate; colorless oil (211 mg, 87%) (α/β = 93:7) (Z/E = 99:1 (NMR)). Data of the major 
isomer: 1H NMR (500 MHz, CDCl3): δ = 6.14 (qt, J = 6.6, 1.4, JSn–H = 129.8 Hz, 1H), 2.56 – 2.40 
(m, 2H), 2.40 – 2.28 (m, 2H), 1.69 (dt, J = 6.5, 1.0 Hz, 3H), 1.57 – 1.40 (m, 6H), 1.38 – 1.26 (m, 6H), 1.01 – 
0.86 (m, 6H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (126 MHz, CDCl3): δ = 179.3, 142.3, 135.8, 35.3, 35.2, 29.4, 
27.5, 20.1, 13.8, 10.2; 119Sn NMR (186 MHz, CDCl3): δ = 51.5 ppm; IR (film, cm
-1): ṽ = 3025, 2956, 2921, 
2872, 2853, 1708, 1455, 1416, 1376, 1291, 1210, 1071, 1021; ESI-MS calcd for C18H35O2Sn (M–H
–) 
403.16639; found 403.16678. 
Note: this product is prone to proto-destannation (ca. 10% after 24h, NMR) 
Ethyl (Z)-2-(tributylstannyl)but-2-enoate and Ethyl (Z)-3-(tributylstannyl)but-2-enoate. Method A: 
Prepared according to the standard procedure as a mixture of 
regioisomers (α/β = 1/1.5) using [Cp*Ru(CH3CN)3]PF6 (5 mol%) as the 
catalyst; colorless oil (72.8 mg, 90%). The Z/E ratio (NMR) was found to be 
99/1 for the β-isomer and >99/1 for the α-isomer. The regioisomers can 
be separated by flash chromatography (SiO2) using hexanes/EtOAc (1/0  50/1  5/1) as the eluent. β-
Isomer: 1H NMR (400 MHz, CDCl3): δ = 6.41 (q, J = 1.7, JSn–H = 106.1 Hz, 1H), 4.17 (q, J = 7.1 Hz, 2H), 2.13 (d, J 
= 1.7 Hz, 3H), 1.54 – 1.37 (m, 6H), 1.36 – 1.23 (m, 9H), 1.07 – 0.91 (m, 6H), 0.88 (t, J = 7.3 Hz, 9H); 13C NMR 
(101 MHz, CDCl3): δ = 171.7, 167.9, 129.4, 60.2, 29.4, 27.6, 27.5, 14.5, 13.9, 11.1; 
119Sn NMR (112 MHz, 
CDCl3): δ = 50.6 ppm; IR (film, cm
-1): ṽ = 2955, 2920, 2871, 2852, 1701, 1600, 1463, 1368, 1315, 1191, 
1099, 1043; ESI-MS calcd for C18H36O2SnNa (M+Na
+) 427.16288; found 427.16337; Characteristic data of the 
α-Isomer: 1H NMR (400 MHz, CDCl3): δ = 7.46 (q, J = 6.9 Hz, JSn–H = 106.1 Hz 1H), 4.15 (q, J = 7.1 Hz, 2H), 1.91 
– 1.85 (m, 3H), 1.56 – 1.42 (m, 6H), 1.37 – 1.24 (m, 9H), 1.09 – 0.92 (m, 6H), 0.88 (t, J = 7.3 Hz, 9H). 13C NMR 
(101 MHz, CDCl3): δ = 171.7, 152.3, 137.4, 60.5, 29.2, 27.4, 19.7, 14.5, 13.8, 11.5. 
Method B: A solution of Bu3SnH (0.22 mmol, 59 μL, 1.1 equiv) in CH2Cl2 (0.5 mL) was added via syringe 
pump over 1.5 h to a solution of ethyl 2-butynoate (23 μL, 0.20 mmol) and [(Cp*RuCl)4] (2.7 mg, 2.5 μmol, 
0.0125 equiv) in CH2Cl2 (1.0 mL) under Ar. Stirring was continued for 15 min once the addition was 
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complete. For work up, all volatile materials were evaporated; the resulting crude product consisted of a 
mixture of regioisomers (α/β = 6/94), with a Z/E ratio of 95/5 for the β-isomer (NMR). Purification by flash 
chromatography (hexane/EtOAc, 50/1) furnished pure ethyl (Z)-3-(tributylstannyl)but-2-enoate (β -isomer) 
as a colorless oil (57.1 mg, 71%).  
Representative Procedure for the trans-Hydrostannation of Terminal Alkynes: Methyl 5-
(tributylstannyl)hex-5-enoate. A solution of methyl hex-5-ynoate (26 μL, 0.20 mmol) and 
tributyltin hydride (0.22 mmol, 59 μL, 1.1 equiv) in CH2Cl2 (0.5 mL) was added dropwise 
over 12 min to a stirred solution of [Cp*Ru(CH3CN)3]PF6 (5.0 mg, 10 μmol, 0.05 equiv)
 in CH2Cl2 (0.5 mL) 
under argon. Once the addition was complete, the mixture was stirred for another 15 min before all volatile 
materials were evaporated. The residue was passed through a short plug of silica, eluting with 
hexanes/EtOAc (20:1) to give the title compound as a mixture of regioisomers (terminal:internal = 3:97) as 
a colorless oil (60.5 mg, 73%). Data of the major isomer: 1H NMR (400 MHz, CDCl3) δ = 5.67 (dt, J = 2.8, 1.5, 
JSn–H = 137.6 Hz, 1H), 5.14 (dt, J = 2.3, 1.0, JSn–H = 62.9 Hz, 1H), 3.66 (s, 3H), 2.37 – 2.20 (m, 4H), 1.77 – 1.66 
(m, 2H), 1.58 – 1.38 (m, 6H), 1.36 – 1.25 (m, 6H), 1.00 – 0.78 (m, 15H); 13C NMR (101 MHz, CDCl3) δ = 174.1, 
154.4, 125.9, 51.6, 40.6, 33.6, 29.3, 27.5, 24.7, 13.8, 9.7; 119Sn NMR (112 MHz, CDCl3): δ = 45.2 ppm; IR 
(film, cm-1): ṽ = 2955, 2925, 2872, 2852, 1742, 1457, 1436, 1376, 1245, 1222, 1193, 1170, 1072; ESI-MS 
calcd for C19H39O2Sn (M+H
+) 419.19713; found 419.19730 
4-(Trimethylsilyl)but-3-yn-1-yl 4-(tributylstannyl)pent-4-enoate. Prepared analogously (using only 1.0 
equiv. of Bu3SnH) as a colorless oil (isomer ratio for stannylation at the terminal 
versus the silylated triple bond = 93:7) (98.2 mg, 96%); 1H NMR (400 MHz, CDCl3): 
δ = 5.70 (dt, J = 2.3, 1.6, JSn–H = 133.2 Hz, 1H), 5.15 (dt, J = 2.3, 1.2, JSn–H = 62.4 Hz, 
1H), 4.16 (t, J = 7.1 Hz, 2H), 2.64 – 2.46 (m, 4H), 2.46 – 2.34 (m, 2H), 1.59 – 1.40 (m, 6H), 1.38 – 1.25 (m, 6H), 
1.00 – 0.82 (m, 15H), 0.15 (s, 9H); 13C NMR (101 MHz, CDCl3): δ = 173.0, 153.1, 125.6, 102.4, 86.6, 62.3, 
35.8, 34.1, 29.2, 27.5, 20.5, 13.8, 9.7, 0.2; 119Sn NMR (112 MHz, CDCl3): δ = 44.0 ppm; IR (film, cm
-1): ṽ = 
2956, 2925, 2872, 2853, 2181, 1741, 1457, 1419, 1377, 1337, 1248, 1162, 1071, 1026; ESI-MS calcd for 
C24H46O2SiSnNa (M+Na
+) 537.21806; found 537.21852. 
Pent-3-yn-1-yl 4-(tributylstannyl)pent-4-enoate. Prepared analogously (using only 1.0 equiv. of Bu3SnH) as 
a colorless oil (isomer ratio for stannylation at the terminal versus the internal triple 
bond = 76:24) (80.6 mg, 89%); 1H NMR (400 MHz, CDCl3): δ = 5.70 (dq, J = 3.5, 1.7, 
JSn–H = 135.0 Hz, 1H), 5.15 (dq, J = 2.0, 1.0, JSn–H = 62.6 Hz, 1H), 4.13 (t, J = 7.0 Hz, 2H), 
2.65 – 2.50 (m, 2H), 2.50 – 2.34 (m, 4H), 1.77 (t, J = 2.5 Hz, 3H), 1.63 – 1.38 (m, 6H), 1.37 – 1.23 (m, 6H), 
1.01 – 0.82 (m, 6H), 0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 173.1, 153.2, 125.5, 77.4, 74.9, 
62.9, 35.8, 34.0, 29.2, 27.5, 19.4, 13.8, 9.7, 3.6; 119Sn NMR (112 MHz, CDCl3): δ = 44.0 ppm; IR (film, cm
-1): 
ṽ = 2955, 2922, 2871, 2852, 1739, 1457, 1419, 1377, 1340, 1245, 1165, 1072, 1002; ESI-MS calcd for 
C22H40O2SnNa (M+Na
+) 479.19418; found 479.19459. 
(Z)-3-(Tributylstannyl)hexadec-2-en-14-yn-4-ol. Prepared according to the standard procedure but using 
[(Cp*RuCl)4] (1.25 mol%) as the catalyst and 1.05 equiv. of Bu3SnH; purification by flash 
chromatography (hexane/EtOAc, 100/1  20/1) allowed minor by-products to be 
removed and gave the title compound as a colorless oil (57.7 mg, 55%). 1H NMR (400 
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MHz, CDCl3): δ = 6.23 (qd, J = 6.6, 1.0, JSn–H = 126.0 Hz, 1H), 4.20 – 3.98 (m, 1H), 2.11 (tq, J = 7.3, 2.5 Hz, 2H), 
1.78 (t, J = 2.5 Hz, 3H), 1.73 (d, J = 6.5 Hz, 3H), 1.57 – 1.40 (m, 9H), 1.40 – 1.18 (m, 20H), 1.06 – 0.87 (m, 6H), 
0.89 (t, J = 7.3 Hz, 9H); 13C NMR (101 MHz, CDCl3): δ = 149.6, 134.8, 80.5, 79.6, 75.4, 37.9, 29.8, 29.7, 29.4, 
29.34, 29.27, 29.1, 27.6, 26.1, 19.4, 18.9, 13.8, 11.1, 3.6; 119Sn NMR (112 MHz, CDCl3): δ = 55.2 ppm; IR 
(film, cm-1): ṽ = 3468, 2954, 2922, 2853, 1462, 1375, 1290, 1148, 1070, 1046, 1004; ESI-MS calcd for 
C28H54OSnNa (M+Na
+) 549.30881; found 549.30917. 
(Z)-4-(Tributylstannyl)-4-(trimethylsilyl)but-3-en-1-ol. Prepared according to the standard procedure as a 
mixture of regioisomers (α/β = 96/4); colorless oil (35.5 mg, 82%). The Z/E ratio (NMR) 
was found to be >99/1 for the α-isomer. 1H NMR (400 MHz, CDCl3): δ = 6.72 (t, J = 6.6, JSn–
H = 170.6 Hz, 1H), 3.73 (t, J = 6.6 Hz, 2H), 2.42 (q, J = 6.6 Hz, 2H), 1.59 – 1.38 (m, 6H), 1.38 
– 1.25 (m, 7H), 1.04 – 0.92 (m, 6H), 0.89 (t, J = 7.3 Hz, 9H), 0.05 (s, 9H); 13C NMR (101 MHz, CDCl3): δ = 
150.8, 148.0, 62.3, 42.5, 29.4, 27.6, 13.8, 11.5, 0.1; 119Sn NMR (112 MHz, CDCl3): δ = 53.7 ppm; IR (film, 
cm-1): ṽ = 3310, 2954, 2923, 2871, 2854, 1571, 1463, 1376, 1245, 1046; ESI-MS calcd for C19H43OSiSn (M+H
+) 
435.21045; found 435.21003. 
 (Z)-4-(Tributylstannyl)-4-(trimethylsilyl)but-3-en-1-yl 4-methoxybenzoate. Prepared according to the 
standard procedure as a mixture of regioisomers (α/β = 98/2); colorless oil (111.7 mg, 
98%); The Z/E ratio (NMR) was found to be >99/1 for the α-isomer. 1H NMR (400 MHz, 
CDCl3) δ = 8.05 – 7.95 (m, 2H), 6.95 – 6.88 (m, 2H), 6.78 (t, J = 6.4, JSn–H = 169.6 Hz, 1H), 4.37 
(t, J = 6.7 Hz, 2H), 3.86 (s, 3H), 2.65 – 2.52 (m, 2H), 1.57 – 1.38 (m, 6H), 1.38 – 1.25 (m, 6H), 
1.06 – 0.92 (m, 6H), 0.88 (t, J = 7.3 Hz, 9H), 0.06 (s, 9H); 13C NMR (101 MHz, CDCl3) δ = 
166.4, 163.5, 150.3, 147.4, 131.7, 123.0, 113.7, 63.9, 55.6, 38.5, 29.4, 27.5, 13.8, 11.4, 0.1; 119Sn NMR (112 
MHz, CDCl3): δ = 53.1 ppm; IR (film, cm
-1): ṽ = 2954, 2926, 2871, 2853, 1715, 1607, 1511, 1459, 1273, 
1254, 1166, 1099, 1033; ESI-MS calcd for C27H49O3SiSn (M+H
+) 569.24723; found 569.24702. 
(Z)-(5-Chloro-5-(tributylstannyl)pent-4-en-1-yl)triethylsilane. Prepared according to the standard 
procedure; colorless oil (47.6 mg, 94%) (α/β = 99:1) (Z/E = 99:1 (NMR)); 1H NMR (400 
MHz, CDCl3) δ = 6.65 (t, J = 6.6, JSn–H = 174.8 Hz, 1H), 3.55 (t, J = 6.7 Hz, 2H), 2.36 – 2.23 
(m, 2H), 1.96 – 1.85 (m, 2H), 1.57 – 1.39 (m, 6H), 1.39 – 1.25 (m, 6H), 1.02 – 0.79 (m, 
24H), 0.56 (q, J = 7.9 Hz, 6H); 13C NMR (101 MHz, CDCl3) δ = 155.3, 141.6, 44.7, 36.9, 32.8, 29.4, 27.6, 13.8, 
11.6, 7.7, 3.9; 119Sn NMR (112 MHz, CDCl3): δ = 54.7 ppm; IR (film, cm
-1): ṽ = 2953, 2927, 2872, 2854, 1570, 
1458, 1376, 1235, 1071, 1003. 
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